Clinical trial
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III…
NCT00004160 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00004160 |
|---|---|
| Title | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed |
| Official title | Sequential and Concomitant Chemoradiotherapy With Gemcitabine-Based Chemotherapy for Inoperable Stage IIIa and IIIb Non-Small Cell Lung Cancer: A Phase I/IIa Study |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, gemcitabine hydrochloride, paclitaxel, radiation therapy |
| Enrollment | 72 |
| Start date | Feb 1, 2000 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jul 19, 2004 |
| Last update posted | Nov 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: